Mar 16, 2021 / 05:50PM GMT
Hartaj Singh - Oppenheimer & Co. Inc., Research Division - Research Analyst
Great. Thank you, John. Hi, everybody. Thanks for joining us back. I hope you had a good lunch or a beer or a nice little break. We have today Tal Zaks, the Chief Medical Officer of Moderna, here with us, joining us in our fireside chat with Moderna. I was just reminding Tal, that he and I met in person for the first time 2 years ago at the Oppenheimer Healthcare Conference. And I just had a really, really great chat with him. And in fact, I can remember pretty much every time whenever we interacted because I've learned a lot from him and his team and what Moderna has done. It has been a historic year since -- over the last year and since last year at our virtual health care conference. So Tal, thank you so very much for joining us.
Tal Zaks - Moderna, Inc. - Chief Medical Officer
It's a real pleasure to be here again. Good to see you. I wish this were in person, but next time, hopefully, it will be in person.
Hartaj Singh - Oppenheimer & Co. Inc.,
Moderna Inc at Oppenheimer Healthcare Conference (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot